Intervention

regular human insulin

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions2

Lead sponsors shown2

Clinical trials

2 shown

Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes MellitusNCT00883558 · 2009-05-01

Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 DiabetesNCT00982254 · 2001-10-01

Common conditions

Diabetes Mellitus, Type 11 Type 2 Diabetes1

Leading sponsors

Halozyme Therapeutics1 Profil Institut für Stoffwechselforschung GmbH1

Trial status mix

COMPLETED2

Phase mix

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.